Evidence map›Paper›PMID 32922575›Full record

ArticlePharmacy practice

Primary health care pharmacists and vision for community pharmacy and pharmacists in Chile.

Francisco Martínez-Mardones, Antonio Ahumada-Canale, Loreto Gonzalez-Machuca, Jose C Plaza-Plaza

Open access · diamondAbstract read
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Francisco Martínez-MardonesBPharm, Mpharm. Department of Pharmaceutical Policies and Regulations, Public Health Division, Public Health SubSecretariat, Chilean Ministry of Health. Santiago de Chile (Chile). francisco.martinez@minsal.cl.ORCID https://orcid.org/0000-0002-7721-1813
Antonio Ahumada-CanaleBPharm, Mpharm. Graduate School of Health, University of Technology Sydney. Ultimo, NSW (Australia). antonioosvaldo.ahumadacanale@uts.edu.au.ORCID https://orcid.org/0000-0001-6806-1422
Loreto Gonzalez-MachucaBPharm, Mpharm. Chief of the Department of Pharmaceutical Policies and Regulations, Public Health Division, Public Health SubSecretariat, Chilean Ministry of Health. Santiago (Chile). loreto.gonzalez@minsal.cl.ORCID https://orcid.org/0000-0003-3582-7836
Jose C Plaza-PlazaBPharm, MPharm, PhD. Assistant Lecturer. Faculty of Chemistry and Pharmacy, Pontifical Catholic University of Chile. Santiago (Chile). jplaza@uc.cl.ORCID https://orcid.org/0000-0003-0724-2152
Ministry of Health · CLPontificia Universidad Católica de Chile · CLUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Chilean healthcare system is composed of public and private sectors, with most of the higher-income population being covered privately. Primary healthcare in the public system is provided in more than 2,500 public primary care centers of different sizes with assigned populations within territories. Private insurance companies have their own healthcare networks or buy services from individual health providers. Patients from the public system receive most medications free of charge in primary care pharmacies embedded in each care center. Private patients must purchase their medicines from community pharmacies. Some government policies subsidize part of the cost of medications, but original medicines remain as the most expensive of Latin America. Three chain pharmacies have more than 90% of the market share, and these pharmacies have negative public perception because of price collusion court sentences. A non-profit, municipal pharmacy model was developed but has limited implementation. Most privately owned independent and chain community pharmacies do not provide pharmaceutical services as there is no remuneration or cover by insurers. The limited number of publicly owned Municipal pharmacies could implement pharmaceutical services in community settings as they are non-profit establishments and have full-time pharmacists but are not resourced for these services. A limited number of pharmaceutical services are almost exclusively provided in public primary care, including medication reviews, pharmaceutical education, home visits and pharmacovigilance services, but several barriers to their implementation remain. A risk-based multimorbidity care model was implemented in 2020 for public primary care with additional employment of part-time pharmacists to provide services. We believe that this model will help pharmacists to optimize their time by prioritizing the much-needed clinical tasks. We propose within this multimorbidity care model that the more time-consuming services are provided to higher risk patients. Pharmacy prescribing i.e. amending or approving changes in medications in primary care for chronic conditions could also be useful for the health system, but pharmacists would require additional training. The landscape for pharmaceutical services for primary care in Chile is promising, but the integration with community pharmacies will not be possible until they are funded by public and private insurance, and the public perception of these establishments is improved.

Indexed as

Ambulatory CareChileCommunity Health ServicesCommunity Pharmacy ServicesDelivery of Health Care, IntegratedPharmaciesPharmacistsPrimary Health CareProfessional Practice

Identifiers

PMID32922575
PMCPMC7470236
OpenAlexW3082822120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.